<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Overview of craniofacial pain
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Overview of craniofacial pain
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Overview of craniofacial pain
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Charles C Ho, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sajid A Khan, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ivan Garza, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Elizabeth Robertson, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard P Goddeau, Jr, DO, FAHA
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 18, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis and management of patients with craniofacial pain can prove daunting even to experienced clinicians. The causes are myriad, and misdiagnosis and mismanagement are common.
        </p>
        <p>
         This topic will provide a brief overview of craniofacial pain. Primary headache syndromes are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3357.html" rel="external">
          "Tension-type headache in adults: Etiology, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3326.html" rel="external">
          "Cluster headache: Epidemiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          NEURALGIAS AND PAINFUL CRANIAL NEUROPATHIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pain from neuralgia occurs in the distribution of a specific nerve or nerves that otherwise are normal in function, while neuropathy is defined as a disturbance of function or pathologic change in a nerve or nerves [
         <a href="#rid1">
          1
         </a>
         ]. Neuropathic pain can be caused by a lesion of the central or peripheral somatosensory nervous system.
        </p>
        <p>
         Head and neck pain is mediated by sensory fibers carried by the following nerves [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Trigeminal
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nervus intermedius
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glossopharyngeal
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vagus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Upper cervical spinal cord roots via the occipital nerves and great auricular nerve
        </p>
        <p>
        </p>
        <p>
         Neuralgic pain has a paroxysmal quality, which is typically maximal at onset and is often described as lancinating, electrical shock–like, or jabbing. There may be a single sharp pain or repetitive pains in succession. The pain can last a fraction of a second or endure for several seconds. There may be a refractory period after the severe pain during which pain will not occur. Some neuralgic conditions have trigger zones (areas that when stimulated provoke an attack) or other triggers.
        </p>
        <p>
         Careful history often reveals nonparoxysmal types of pain, such as continuous aching, burning, or throbbing pain. Inquiries must be made about all the sensations that occur, as some patients mention only the severe exacerbations. The response to treatment may provide a clue to diagnosis but can also prove misleading; "diagnostic blocks" in the setting of facial pain do not necessarily define the site from which the pain arises because of the overlap of cranial nerves V, VII, IX, X, which converge on the spinal trigeminal nucleus.
        </p>
        <p>
         The mechanisms of neuropathic pain are complex. A nerve injury can induce peripheral and central changes that contribute to persistent pain and abnormal sensation. Through different mechanisms (inflammation, nociceptor activation, tissue injury), primary afferent fibers and central structures become sensitized. These processes are terminated under normal circumstances as tissues heal and inflammation declines. However, they can persist if primary afferent function is modified by disease, even in the absence of inflammation. While injury of primary afferent fibers results in peripheral neuropathic pain, direct damage to central nervous system structures results in central pain [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H93882323">
         <span class="h2">
          Trigeminal neuralgia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Trigeminal neuralgia is one of the most well-defined and common causes of facial pain. The pain of trigeminal neuralgia tends to occur in paroxysms and is maximal at or near onset. The pain has been described as electric shock–like or stabbing. Trigeminal neuralgia is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5283.html" rel="external">
          "Trigeminal neuralgia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1652448">
         <span class="h2">
          Painful trigeminal neuropathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Painful trigeminal neuropathy, also known as anesthesia dolorosa, is defined by head and/or facial pain in an area of reduced or absent sensation occurring in the distribution of one or more branches of the trigeminal nerve [
         <a href="#rid1">
          1
         </a>
         ]. This condition is an example of how difficult central pain can be to describe since the patient has sensory loss but, at the same time, can feel pain. Potential causes include acute herpes zoster, postherpetic neuralgia (PHN), trauma, and others (eg, neural/perineural neoplasm). Painful trigeminal neuropathy can also be classified as idiopathic when clinical evaluation and thorough diagnostic testing identifies no underlying cause [
         <a href="#rid1">
          1,3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H314304663">
         <span class="h3">
          Postherpetic neuralgia
         </span>
         <span class="headingEndMark">
          —
         </span>
         PHN is a type of painful cranial neuropathy associated with an acute herpes zoster infection. PHN is diagnosed as neuropathic pain that occurs in a distribution of a preceding herpes zoster attack and persists beyond three months after onset of the acute herpes zoster rash. PHN most often represents a continuum of pain that never resolved following an acute episode of herpes zoster. However, in rare cases, PHN can occur months to years after resolution of the initial event. The epidemiology, pathogenesis, diagnosis, and treatment of PHN are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5289.html" rel="external">
          "Postherpetic neuralgia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H93882621">
         <span class="h3">
          Painful post-traumatic trigeminal neuropathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Painful post-traumatic trigeminal neuropathy is characterized by unilateral facial or oral pain that occurs after traumatic injury of the trigeminal nerve, accompanied by additional symptoms or signs of trigeminal nerve dysfunction [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Diagnostic criteria for painful post-traumatic trigeminal neuropathy, according to the International Classification of Headache Disorders, 3
         <sup>
          rd
         </sup>
         edition (ICHD-3), require all of the following [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Facial and/or oral pain in the distribution of one or both trigeminal nerves
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of an identifiable traumatic event to the trigeminal nerve, with clinically evident positive (hyperalgesia, allodynia) and/or negative (hypoesthesia, hypoalgesia) signs of trigeminal nerve dysfunction
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evidence of causation demonstrated by both of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pain is located in the distribution(s) of the trigeminal nerve(s) affected by the traumatic event
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pain has developed within six months of the traumatic event
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Not better accounted for by another ICHD-3 diagnosis
        </p>
        <p>
        </p>
        <p>
         The causative traumatic event may be mechanical, chemical, thermal, or radiation induced. Although sometimes related to surgical trauma, painful post-traumatic trigeminal neuropathy most frequently occurs as a complication of rhizotomy or thermocoagulation done to treat trigeminal neuralgia. In case series of patients treated for trigeminal neuralgia, painful post-traumatic trigeminal neuropathy has developed after glycerol rhizotomy in 0 to 1.6 percent of cases [
         <a href="#rid4">
          4-8
         </a>
         ], after radiofrequency rhizotomy in 0.8 to 2 percent [
         <a href="#rid9">
          9,10
         </a>
         ], and following percutaneous controlled thermocoagulation in 3 percent [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         Painful post-traumatic trigeminal neuropathy can be more intolerable than the pain from trigeminal neuralgia itself [
         <a href="#rid12">
          12
         </a>
         ]. This risk warrants careful decision making when considering surgical treatment for trigeminal neuralgia. (See
         <a class="medical medical_review" href="/z/d/html/5283.html" rel="external">
          "Trigeminal neuralgia", section on 'Surgery for medically refractory TN'
         </a>
         .)
        </p>
        <p>
         For treatment of non-neuralgic painful post-traumatic trigeminal neuropathy, we suggest tricyclic antidepressants (eg,
         <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">
          amitriptyline
         </a>
         ) as initial pharmacologic therapy. When tricyclic medications are contraindicated or poorly tolerated,
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         or
         <a class="drug drug_general" data-topicid="9473" href="/z/d/drug information/9473.html" rel="external">
          pregabalin
         </a>
         are preferred alternative choices. For superimposed neuralgiform pain,
         <a class="drug drug_general" data-topicid="9198" href="/z/d/drug information/9198.html" rel="external">
          carbamazepine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9467" href="/z/d/drug information/9467.html" rel="external">
          oxcarbazepine
         </a>
         , and
         <a class="drug drug_general" data-topicid="9062" href="/z/d/drug information/9062.html" rel="external">
          baclofen
         </a>
         are often used in clinical practice as in other cranial neuralgias.
        </p>
        <p class="headingAnchor" id="H354058645">
         <span class="h3">
          Trigeminal trophic syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The trigeminal trophic syndrome is characterized by facial skin ulceration and dysesthesia related to damage in the trigeminal nerve pathway affecting either peripheral components such as the trigeminal nerve (including the trigeminal ganglion and sensory root) or its central sensory nuclei [
         <a href="#rid13">
          13-17
         </a>
         ]. The most frequent causes are therapeutic trigeminal nerve ablation and ischemic medullary or pontine stroke; others include craniofacial surgery, trauma, and herpes zoster infection [
         <a href="#rid15">
          15
         </a>
         ]. Higher trigeminal pathway injuries affecting the trigemino-thalamic or thalamo-cortical tracts have not been reported to cause trigeminal trophic syndrome.
        </p>
        <p>
         The most common symptoms of trigeminal trophic syndrome are bothersome dysesthesia, including itching, tickling, crawling, burning, as well as ocular foreign body and nasal airflow obstruction sensations [
         <a href="#rid13">
          13-17
         </a>
         ]. Approximately one-half of affected individuals report facial pain. Examination reveals facial hypoesthesia or anesthesia. Skin ulceration tends to occur in the distribution of the infraorbital nerve, although it can occur in other trigeminal distributions [
         <a href="#rid15">
          15
         </a>
         ]. The exact mechanisms for ulcer development have not been determined; self-manipulation with rubbing and scratching of the dysesthetic regions appears to be a contributing factor and can lead to erosion of the nasal ala and corneal lesions.
        </p>
        <p>
         There is no established treatment for trigeminal trophic syndrome, though
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         and
         <a class="drug drug_general" data-topicid="9198" href="/z/d/drug information/9198.html" rel="external">
          carbamazepine
         </a>
         are often used to control dysesthetic symptoms [
         <a href="#rid16">
          16,18,19
         </a>
         ]. Associated neuralgic pain may respond better to carbamazepine,
         <a class="drug drug_general" data-topicid="9467" href="/z/d/drug information/9467.html" rel="external">
          oxcarbazepine
         </a>
         , or
         <a class="drug drug_general" data-topicid="9062" href="/z/d/drug information/9062.html" rel="external">
          baclofen
         </a>
         . Measures to protect the injured area and promote healing may be beneficial; these include protective facial prosthetics and dressings, fingernail trimming, use of nocturnal scratch mittens, and behavioral modification.
        </p>
        <p class="headingAnchor" id="H93882329">
         <span class="h2">
          Cluster-tic syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cluster-tic syndrome is a combination of cluster headache with coexistent trigeminal neuralgia [
         <a href="#rid1">
          1,20-22
         </a>
         ]. The term "tic" refers to tic douloureux, another term for trigeminal neuralgia. It is characterized by three types of pain [
         <a href="#rid20">
          20,21
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         One component resembles the pain of trigeminal neuralgia and is paroxysmal, short lasting, and severe. (See
         <a class="medical medical_review" href="/z/d/html/5283.html" rel="external">
          "Trigeminal neuralgia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The second component is characterized by trigeminal autonomic cephalalgia more like a cluster headache, although of variable length, with autonomic phenomena (eg, ptosis, miosis, lacrimation, conjunctival injection, rhinorrhea, nasal congestion). (See
         <a class="medical medical_review" href="/z/d/html/3326.html" rel="external">
          "Cluster headache: Epidemiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The third type of pain is a mixture of the first two and may be provoked by trigger points or moving the neck.
        </p>
        <p>
        </p>
        <p>
         Cluster-tic syndrome usually affects patients between 20 and 70 years of age. It may exist in chronic or episodic (remissions and recurrences) forms. In one series, trigeminal neuralgia co-occurred with cluster headache in 4.5 percent of patients [
         <a href="#rid23">
          23
         </a>
         ]. Some patients with this multifeatured headache syndrome have brief and recurring trigeminal autonomic cephalalgia symptoms more like short-lasting unilateral neuralgiform headache attacks than cluster attacks  (
         <a class="graphic graphic_table graphicRef65541" href="/z/d/graphic/65541.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid24">
          24,25
         </a>
         ].
        </p>
        <p>
         Patients with cluster-tic syndrome require treatment directed at both cluster headache and trigeminal neuralgia in order to achieve remission of headaches [
         <a href="#rid1">
          1,26
         </a>
         ]. Medical therapy usually consists of a combination of drugs used to treat trigeminal neuralgia and cluster headache and is often unsuccessful. Treatment of underlying causes such as demyelination or interventional and surgical treatment for structural contributors to symptoms may be warranted [
         <a href="#rid27">
          27-29
         </a>
         ]. It is reported that if surgical microvascular decompression relieves the neuralgia, the cluster-like pain may be lessened and become more responsive to medical therapy [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Glossopharyngeal neuralgia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Glossopharyngeal neuralgia is an uncommon cranial neuralgia characterized by paroxysmal, severe, stabbing pain involving the ear, tonsillar fossa, base of the tongue, or beneath the angle of the jaw. It is typically triggered by activities that activate the glossopharyngeal nerve such as swallowing, coughing, speaking, yawning, certain tastes, or touching the neck or external auditory canal (rarely the pre- or postauricular areas). The epidemiology, pathogenesis, diagnosis, and treatment of glossopharyngeal neuralgia are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/141179.html" rel="external">
          "Glossopharyngeal neuralgia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Nervus intermedius neuralgia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nervus intermedius (sensory branch of facial nerve) neuralgia is a rare disorder characterized by brief paroxysms of pain felt deeply in the auditory canal. Other terms used are geniculate neuralgia or Hunt neuralgia. The epidemiology, pathogenesis, diagnosis, and treatment of nervus intermedius neuralgia are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3331.html" rel="external">
          "Nervus intermedius neuralgia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1764868837">
         <span class="h2">
          Auricular neuralgias
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other uncommon neuralgias that primarily affect the ear include great auricular neuralgia and auriculotemporal neuralgia.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Great auricular neuralgia is an uncommon cause of neuralgic pain in the preauricular region. Pain can be triggered by head turning, neck touch, change of neck position during sleep, and jaw movement [
         <a href="#rid31">
          31,32
         </a>
         ]. The great auricular nerve arises from C2 and C3 nerve roots, emerges from the midpoint of the sternocleidomastoid muscle, and ascends as it splits into preauricular and posterior branches where it provides innervation over the skin in the preauricular region, jaw angle, posteroinferior pinna and mastoid [
         <a href="#rid31">
          31
         </a>
         ]. Symptoms may be idiopathic or secondary to a structural process (eg, lymphoma). It can be injured during procedures such as parotidectomy, submandibular gland resection, rhytidectomy, cervical lymph node dissection, trauma, carotid endarterectomy, and pacemaker placement.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Auriculotemporal neuralgia presents with neuralgic pain in the ear, temple, and preauricular regions [
         <a href="#rid33">
          33,34
         </a>
         ]. The auriculotemporal nerve is a terminal branch of the mandibular (V3) nerve that encircles the middle meningeal artery and passes posteromedially to the mandibular condyle where it supplies sensation to the anterolateral aspect of the temporomandibular joint (TMJ) capsule, external acoustic meatus, anterior auricle, tragus, parotid gland, and the skin along the temple [
         <a href="#rid35">
          35
         </a>
         ]. Entrapment, compression, inflammatory conditions, middle meningeal artery aneurysm, mandibular condyle fracture, perineural tumor spread, and TMJ synovial cysts have all been reported as possible causes [
         <a href="#rid33">
          33,35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Occipital neuralgia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Occipital neuralgia can be a cause of headache in the occipital region. It is described as a paroxysmal jabbing pain in the greater, lesser, and/or third occipital nerve distribution, infrequently accompanied by diminished sensation or dysesthesia in the affected area. Tenderness overlying the nerve affected may be present. The epidemiology, pathogenesis, diagnosis, and treatment of occipital neuralgia are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3330.html" rel="external">
          "Occipital neuralgia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3953265163">
         <span class="h1">
          OTHER CAUSES OF FACIAL PAIN
         </span>
        </p>
        <p class="headingAnchor" id="H93882470">
         <span class="h2">
          Optic neuritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Headache due to optic neuritis (painful optic neuritis) is characterized by pain behind one or both eyes caused by optic nerve demyelination with associated central vision impairment [
         <a href="#rid1">
          1
         </a>
         ]. Optic neuritis is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5251.html" rel="external">
          "Optic neuritis: Pathophysiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H93882477">
         <span class="h2">
          Headache attributed to ischemic ocular motor nerve palsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Headache caused by ischemic injury of the ipsilateral cranial nerves III, IV, or VI (ie, attributed to ischemic palsy of ocular motor nerves) is described as a unilateral frontal and/or periorbital pain caused by and associated with other symptoms and signs of ischemic injury of the ocular nerves that control eye movements [
         <a href="#rid1">
          1
         </a>
         ]. This is most prevalent with ischemic injury to cranial nerve III and may occur regardless of the presence or absence of underlying diabetes. (See
         <a class="medical medical_review" href="/z/d/html/5246.html" rel="external">
          "Third cranial nerve (oculomotor nerve) palsy in adults"
         </a>
         .)
        </p>
        <p>
         Patients with transient and recurrent ocular motor palsies that are not clearly associated with ischemia should be evaluated for recurrent painful ophthalmoplegia neuropathy. (See
         <a class="local">
          'Recurrent painful ophthalmoplegic neuropathy'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H93882484">
         <span class="h2">
          Tolosa-Hunt syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Headache due to Tolosa-Hunt syndrome is described as unilateral orbital pain associated with paresis of one or more of cranial nerves III, IV, or VI caused by a granulomatous inflammation in the cavernous sinus, superior orbital fissure, or orbit. This condition is reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5248.html" rel="external">
          "Tolosa-Hunt syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Paratrigeminal oculosympathetic syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The paratrigeminal oculosympathetic syndrome (also known as Raeder syndrome) consists of constant unilateral burning facial pain with hypesthesia and/or dysesthesia in the distribution of the ophthalmic division of the trigeminal nerve, along with ptosis and miosis [
         <a href="#rid36">
          36
         </a>
         ]. This syndrome may be caused by trauma, middle cranial fossa mass lesion, syphilis, and sinusitis. As an example, a restricted lesion in the middle cranial fossa can directly compromise trigeminal nerve fibers and cause neuralgic pain or sensory change with ptosis and/or miosis but no anhidrosis [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
         Diagnostic criteria for the paratrigeminal oculosympathetic syndrome, according to the International Classification of Headache Disorders, 3
         <sup>
          rd
         </sup>
         edition (ICHD-3), require all of the following [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Constant, unilateral headache
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ipsilateral Horner syndrome, with imaging evidence of underlying disease of either the middle cranial fossa or of the ipsilateral carotid artery
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evidence of causation demonstrated by both of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Headache has developed in temporal relation to the onset of the underlying disorder or led to its discovery
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Headache has either or both of the following features:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Localized to the distribution of the ophthalmic division of the trigeminal nerve, with or without spread to the maxillary division
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Aggravated by eye movement
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Not better accounted for by another ICHD-3 diagnosis
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H93882498">
         <span class="h2">
          Recurrent painful ophthalmoplegic neuropathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recurrent painful ophthalmoplegic neuropathy (RPON), previously called ophthalmoplegic migraine, is a rare condition most often seen in children and young adults. It is characterized by repeated attacks of paralysis of one or more ocular cranial nerves, typically cranial nerve III, after the onset of an ipsilateral headache [
         <a href="#rid1">
          1
         </a>
         ]. Headache can develop up to two weeks before the onset of eye muscle weakness. In one review of 165 cases, cranial nerve III dysfunction was seen in 54 percent, cranial nerve VI in 37 percent, cranial nerve IV in 4 percent, and multiple cranial nerve involvement in 4 percent [
         <a href="#rid38">
          38
         </a>
         ]. In unusual cases, it may present with isolated pupillary paralysis (internal ophthalmoplegia) due to oculomotor parasympathetic paresis [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
         The former term for this condition (ophthalmoplegic migraine) has been rejected because the syndrome is not migrainous [
         <a href="#rid1">
          1
         </a>
         ]. Brain magnetic resonance imaging (MRI) reveals asymmetric thickening or gadolinium enhancement of the cisternal segment of the affected cranial nerve in approximately 30 percent of all cases [
         <a href="#rid38">
          38
         </a>
         ]. However, when restricted to childhood-onset cases or acute presentations, these MRI findings may be found in more than 60 percent [
         <a href="#rid38">
          38,40
         </a>
         ]. RPON may be due to recurrent episodes of demyelination [
         <a href="#rid40">
          40,41
         </a>
         ], but the underlying causes and classification remain somewhat controversial [
         <a href="#rid42">
          42-46
         </a>
         ]. In rare cases, oculomotor nerve tumors may mimic RPON; clues to the presence of tumor include incomplete recovery of ophthalmoplegia between attacks and the presence of a contrast-enhancing nodule of the oculomotor nerve on brain MRI [
         <a href="#rid47">
          47-51
         </a>
         ].
        </p>
        <p>
         Diagnostic criteria for RPON, according to the ICHD-3, require all of the following [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         At least two attacks
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Both of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Unilateral headache
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ipsilateral paresis of one, two or all three oculomotor nerves
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Orbital, parasellar, or posterior fossa lesion has been excluded by appropriate investigation
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Not better accounted for by another ICHD-3 diagnosis
        </p>
        <p>
        </p>
        <p>
         Observational data suggest that treatment with glucocorticoids is beneficial for some patients [
         <a href="#rid1">
          1,38,40
         </a>
         ]. In the absence of data to guide therapy, a short course of
         <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">
          prednisone
         </a>
         at 60 mg daily decreasing by 10 mg every three days is reasonable. Patients should follow up clinically and to assess efficacy as symptoms dictate. Symptoms typically last from a few days to up to two months, but recovery may be partial in some patients with multiple severe episodes [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1651832">
         <span class="h2">
          Burning mouth syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Burning mouth syndrome is characterized by an intraoral burning sensation for which no medical or dental cause can be found [
         <a href="#rid1">
          1
         </a>
         ]. Pain may be restricted to the tongue or just the tip of the tongue and may be associated with dysesthesia, altered taste, and/or a sensation of having a dry mouth. This uncommon condition predominantly affects postmenopausal females [
         <a href="#rid52">
          52,53
         </a>
         ], and 30 to 50 percent of patients improve spontaneously [
         <a href="#rid54">
          54
         </a>
         ]. In a population-based epidemiologic study from Olmsted County, burning mouth syndrome was most commonly diagnosed after age 80 years [
         <a href="#rid55">
          55
         </a>
         ]. An etiologic role for psychologic factors such as anxiety and depression has been suggested [
         <a href="#rid56">
          56-58
         </a>
         ].
        </p>
        <p>
         Although no definitive etiology has been established, one study suggested that trigeminal small-fiber sensory neuropathy is the cause of so-called idiopathic burning mouth syndrome [
         <a href="#rid59">
          59
         </a>
         ]. Other studies identified a significantly higher number of unoccupied D2 dopamine receptors in the putamen associated with painful clinical conditions [
         <a href="#rid60">
          60
         </a>
         ]. In this regard, a report described a patient with burning mouth syndrome whose pain responded to
         <a class="drug drug_general" data-topicid="9560" href="/z/d/drug information/9560.html" rel="external">
          pramipexole
         </a>
         , a nonergot dopamine agonist with a high selectivity for dopaminergic D2 receptors [
         <a href="#rid61">
          61
         </a>
         ]. A subsequent case series reported six patients who failed other therapies but improved after treatment with pramipexole [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p>
         Diagnostic criteria for burning mouth syndrome, according to the ICHD-3, require all of the following [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral pain
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recurring daily for more than two hours per day for greater than three months
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pain has both of the following characteristics:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Burning quality
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Felt superficially in the oral mucosa
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral mucosa is of normal appearance, and clinical examination including sensory testing is normal
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Not better accounted for by another ICHD-3 diagnosis
        </p>
        <p>
        </p>
        <p>
         Prior to making the diagnosis, it is important to rule out oral mucosal diseases, such as herpes simplex and aphthous stomatitis. Other common conditions associated with mouth pain are psychiatric disorders, xerostomia (from drugs, connective tissue disease, or age), nutritional deficiencies (vitamin B12, iron, folate, zinc, vitamin B6), and allergic contact stomatitis. More unusual causes of mouth pain include geographic tongue, candidiasis, diabetes, denture-related pain, thyroid abnormalities, laryngopharyngeal reflux, and menopause [
         <a href="#rid63">
          63-65
         </a>
         ]. Treating the underlying cause of mouth pain, if found, usually results in the remission of the symptoms [
         <a href="#rid54">
          54
         </a>
         ]. When no underlying cause of symptoms is found, the condition is considered idiopathic burning mouth syndrome.
        </p>
        <p>
         We suggest
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         or
         <a class="drug drug_general" data-topicid="9473" href="/z/d/drug information/9473.html" rel="external">
          pregabalin
         </a>
         as initial pharmacologic therapy for idiopathic burning mouth syndrome. Other alternatives or adjunctive treatments include
         <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">
          amitriptyline
         </a>
         ,
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          clonazepam
         </a>
         , oral or topical
         <a class="drug drug_general" data-topicid="8840" href="/z/d/drug information/8840.html" rel="external">
          capsaicin
         </a>
         , and alpha-lipoic acid. Systematic reviews of treatment trials for burning mouth syndrome found several medications may be effective, including oral and topical clonazepam, gabapentin, pregabalin, oral or topical capsaicin, and alpha lipoic acid [
         <a href="#rid66">
          66,67
         </a>
         ]. The quality of evidence to support the efficacy of alpha lipoic acid is low, but it may have a role as adjunctive treatment in combination with other agents [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4027341249">
         <span class="h2">
          Red ear syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The red ear syndrome (RES) is an uncommon entity characterized by unilateral erythema and burning pain of the ear and adjacent face or hemicranium [
         <a href="#rid68">
          68,69
         </a>
         ]. Less commonly, both ears may be involved. Symptoms may occur spontaneously or be triggered by touch, heat, neck movement, eating, or other stimuli. Episodes typically last less than one hour, and recurrence varies widely from monthly to multiple times each day. Symptoms occasionally occur as part of migraine or another primary headache syndrome. (See
         <a class="medical medical_review" href="/z/d/html/3334.html" rel="external">
          "Paroxysmal hemicrania: Clinical features and diagnosis", section on 'Atypical features'
         </a>
         .)
        </p>
        <p>
         The underlying mechanisms are uncertain, but RES has been associated with upper cervical spine disorders in some cases and migraine or trigeminal autonomic cephalgias in others [
         <a href="#rid68">
          68
         </a>
         ]. RES may be a variant form of erythromelalgia, a clinical syndrome characterized by intermittently red and painful extremities [
         <a href="#rid70">
          70,71
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Pathophysiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3339.html" rel="external">
          "Pathophysiology of the trigeminal autonomic cephalalgias"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13766.html" rel="external">
          "Erythromelalgia"
         </a>
         .)
        </p>
        <p>
         Treatment options derived mostly from case reports and series.
         <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">
          Indomethacin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">
          propranolol
         </a>
         ,
         <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">
          amitriptyline
         </a>
         , and
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         have been beneficial in some cases [
         <a href="#rid70">
          70,72,73
         </a>
         ]. Local therapies such as ice packs and nerve blockade have also been used [
         <a href="#rid72">
          72,74-76
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1651597">
         <span class="h2">
          Persistent idiopathic facial pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Persistent idiopathic facial pain (previously known as atypical facial pain) is characterized by persistent facial and/or oral pain in the absence of a neurologic deficit [
         <a href="#rid1">
          1
         </a>
         ]. In a study of Dutch primary care patients, the incidence was 39.5 per 100,000 person-years [
         <a href="#rid77">
          77
         </a>
         ]. Most cases are found in female patients [
         <a href="#rid78">
          78,79
         </a>
         ]. In a German cohort of 150 patients, the mean age of onset was 43 years [
         <a href="#rid79">
          79
         </a>
         ]. The symptoms may follow minor surgery or mild injury to the face, teeth, or gums and persist after healing without a clear local cause [
         <a href="#rid1">
          1
         </a>
         ]. The pain is commonly felt in the nasolabial fold or one side of the chin but can spread to wider areas of the face and neck.
        </p>
        <p>
         Diagnostic criteria for persistent idiopathic facial pain, according to the ICHD-3, require all of the following [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Facial and/or oral pain
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recurring daily for more than two hours per day for more than three months
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pain has both of the following characteristics:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Poorly localized and not following the distribution of a peripheral nerve
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dull, aching, or nagging quality
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Clinical neurologic examination is normal
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A dental cause has been excluded by appropriate investigations
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Not better accounted for by another ICHD-3 diagnosis
        </p>
        <p>
        </p>
        <p>
         Persistent idiopathic facial pain is a diagnosis of exclusion; potential structural lesions, such as craniofacial neoplasms or abscesses, among others, need to be ruled out. Because it is essentially a face pain without a clear cause, persistent idiopathic facial pain is sometimes attributed to a psychogenic etiology [
         <a href="#rid80">
          80
         </a>
         ]. However, this is not appropriate since there is enough reason to believe that persistent idiopathic facial pain is a central pain syndrome [
         <a href="#rid54">
          54,81
         </a>
         ]. Although depression may be present, there is no evidence to support depression as the etiology [
         <a href="#rid80">
          80
         </a>
         ].
        </p>
        <p>
         For persistent idiopathic facial pain, tricyclic antidepressants (eg,
         <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">
          amitriptyline
         </a>
         ) are the preferred treatment [
         <a href="#rid82">
          82
         </a>
         ]. When tricyclic medications are contraindicated or poorly tolerated,
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         or
         <a class="drug drug_general" data-topicid="9473" href="/z/d/drug information/9473.html" rel="external">
          pregabalin
         </a>
         are preferred alternative choices. In one case report,
         <a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">
          topiramate
         </a>
         (titrated to 125 mg two times a day) was beneficial [
         <a href="#rid83">
          83
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H93373286">
         <span class="h2">
          Central neuropathic facial pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         By definition, central neuropathic facial pain is caused by a lesion or dysfunction in the central nervous system. The ICHD-3 recognizes two entities that are central causes of facial pain [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Central neuropathic pain attributed to multiple sclerosis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Central poststroke pain
        </p>
        <p>
        </p>
        <p>
         These are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3324.html" rel="external">
          "Central neuropathic facial pain"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Secondary causes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Secondary causes of craniofacial pain include the following conditions:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cancer pain
         </strong>
         – Cancer is a rare cause of facial pain. Extracranial bony or soft tissue metastases may impinge upon cranial and upper cervical nerves causing headache or facial pain. In addition, occult lung neoplasms may cause referred pain in the periauricular region. Facial pain due to cancer is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2804.html" rel="external">
          "Overview of cancer pain syndromes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dental pain
         </strong>
         – Dental pathology is a common cause of facial pain [
         <a href="#rid84">
          84
         </a>
         ]. Specific inquiry regarding prior dental procedures should be made of all patients with facial pain. The presence of provocative factors such as chewing or heat or cold sensitivity may provide useful clues. Trigeminal neuralgia also has been associated with ipsilateral dental pathology.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Temporomandibular joint syndrome
         </strong>
         – Temporomandibular joint (TMJ) syndrome is characterized by chronic or acute musculoskeletal pain with dysfunction of the masticatory system. Many patients complain of headache or facial pain; in some cases, the disorder presents only as a headache without the patient being aware of a TMJ disturbance. The typical headache associated with TMJ syndrome presents as unilateral ear or preauricular pain that radiates to the jaw, temple, or neck. The pain is deep, dull, continuous, and usually worse in the morning. (See
         <a class="medical medical_review" href="/z/d/html/5629.html" rel="external">
          "Temporomandibular disorders in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Giant cell arteritis
         </strong>
         – Giant cell arteritis (GCA) is a chronic vasculitis of large and medium-sized vessels. Although systemic illness is characteristic of GCA and vascular involvement may be widespread, blood vessel inflammation most frequently involves the cranial branches of the arteries that originate from the aortic arch. The most feared complication of GCA, visual loss, is one potential result of the cranial arteritis associated with this disease. A new type of headache occurs in at least two-thirds of individuals affected with GCA. The head pain tends to be located over the temporal areas but can be frontal or occipital in location. The headaches may be mild or severe. The course is also variable; the headaches may become progressively worse but can subside before treatment is started in some cases. Nearly one-half of GCA patients suffer from jaw claudication. In some cases, a trismus-like symptom occurs rather than fatigue of the chewing muscles. Tender temporal or occipital arteries are found in approximately one-third of patients. (See
         <a class="medical medical_review" href="/z/d/html/8225.html" rel="external">
          "Clinical manifestations of giant cell arteritis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Carotidynia
         </strong>
         – The ICHD-3 recognizes a subtype of headache attributed to noninflammatory lesions affecting the cervical carotid or vertebral arteries [
         <a href="#rid1">
          1
         </a>
         ]. This category includes pain from arterial dissection, postendarterectomy headache, and headache attributed to carotid or vertebral angioplasty. Carotidynia is an older term that was used for pain that appears to emanate from the carotid artery [
         <a href="#rid85">
          85
         </a>
         ]. Rather than a distinct entity, carotidynia is now considered a syndrome that encompasses many varieties of pain, including carotid dissection. (See
         <a class="medical medical_review" href="/z/d/html/14082.html" rel="external">
          "Cerebral and cervical artery dissection: Clinical features and diagnosis", section on 'Local symptoms'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Post-traumatic and postoperative pain
         </strong>
         – Facial pain can occur after trauma, including bullet wounds or other head injuries and surgery. Facial pain may occur after maxillofacial surgery, orbital enucleations, sinus, and dental procedures. Dental procedures can trigger a variety of syndromes, including neuralgia and facial migraine. In all cases of post-traumatic facial pain, a careful search must be conducted for underlying pathology, especially dental problems. Some patients manifest constant burning pain, occasionally with tingling and stabbing but without the trophic changes, edema, and redness that are characteristic of reflex sympathetic dystrophy (complex regional pain syndrome) [
         <a href="#rid86">
          86
         </a>
         ]. Treatment of post-traumatic facial pain can be extremely difficult. Blockade of the stellate ganglion may be effective in patients who complain of significant burning pain. Brief lancinating pains may respond to agents useful for neuralgias.
         <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">
          Amitriptyline
         </a>
         , for example, can reduce pain and lessen associated depression. Other agents useful for treating migraine headaches have been employed empirically for symptomatic benefit. Post-traumatic facial pain generally resolves spontaneously within several years.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3130181700">
         <span class="h2">
          Primary headaches
         </span>
         <span class="headingEndMark">
          —
         </span>
         Finally, primary headaches including migraine, cluster, and other headaches (such as paroxysmal hemicrania) can present mainly in the face. Careful attention to details of the history and examination should clarify the diagnosis. Questions revealing a family history, trigger factors, or the presence of an aura point toward migraine as the etiology. Similarly, cluster headache and other short-lasting headaches may present with pain principally in the face rather than periorbital or retro-orbital regions. Characterizing the duration of the episodes, along with any associated autonomic features (ptosis, rhinorrhea, lacrimation), is diagnostically helpful. (See
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3326.html" rel="external">
          "Cluster headache: Epidemiology, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3334.html" rel="external">
          "Paroxysmal hemicrania: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3336.html" rel="external">
          "Short-lasting unilateral neuralgiform headache attacks: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2323848816">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/115871.html" rel="external">
          "Society guideline links: Neuropathic pain"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10752212">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/16844.html" rel="external">
          "Patient education: Trigeminal neuralgia (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H109166712">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neuralgias and cranial neuropathies
         </strong>
         – Neuralgia is defined as paroxysmal pain in the distribution of a specific nerve, which otherwise has normal function, while neuropathy is defined as a disturbance of function or pathologic change in a nerve or nerves. Neuralgias and painful cranial neuropathies that cause craniofacial pain include the following (see
         <a class="local">
          'Neuralgias and painful cranial neuropathies'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Trigeminal neuralgia
         </strong>
         is characterized by recurrent paroxysms of pain in the distribution of one or more branches of cranial nerve V. (See
         <a class="local">
          'Trigeminal neuralgia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Painful trigeminal neuropathy
         </strong>
         is defined by head and/or facial pain in the distribution of one or more branches of the trigeminal nerve caused by another disorder and indicative of neural damage. (See
         <a class="local">
          'Painful trigeminal neuropathy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cluster-tic syndrome
         </strong>
         is a combination of cluster headache with coexistent trigeminal neuralgia. It is characterized by the pain of trigeminal neuralgia and a cluster headache with autonomic phenomena. (See
         <a class="local">
          'Cluster-tic syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Glossopharyngeal neuralgia
         </strong>
         is defined as paroxysmal pain in areas innervated by cranial nerves IX. (See
         <a class="local">
          'Glossopharyngeal neuralgia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Nervus intermedius neuralgia
         </strong>
         is a rare disorder characterized by brief paroxysms of pain felt in the auditory canal. (See
         <a class="local">
          'Nervus intermedius neuralgia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Auricular neuralgias
         </strong>
         include great auricular neuralgia and auriculotemporal neuralgia. They are rare disorders that cause paroxysms of pain in the ear and adjacent structures. (See
         <a class="local">
          'Auricular neuralgias'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Occipital neuralgia
         </strong>
         is characterized by paroxysmal jabbing pain in the greater, lesser, and/or third occipital nerve distribution, sometimes accompanied by diminished sensation or dysesthesia in the affected area. (See
         <a class="local">
          'Occipital neuralgia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other causes of facial pain
         </strong>
         – Other causes of facial pain include the following conditions:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Optic neuritis
         </strong>
         is characterized by pain behind the eye that is secondary to demyelination of the optic nerve with associated central vision impairment. (See
         <a class="local">
          'Optic neuritis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Headache attributed to ischemic ocular motor nerve palsy
         </strong>
         is a unilateral frontal and/or periorbital pain caused by ischemic injury of the ipsilateral cranial nerves III, IV, or VI that control eye movements. (See
         <a class="local">
          'Headache attributed to ischemic ocular motor nerve palsy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Tolosa-Hunt syndrome
         </strong>
         manifests as unilateral orbital pain associated with paresis of one or more of cranial nerves III, IV, or VI caused by a granulomatous inflammation in the cavernous sinus, superior orbital fissure, or orbit. (See
         <a class="local">
          'Tolosa-Hunt syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Paratrigeminal oculosympathetic syndrome
         </strong>
         consists of constant unilateral burning facial pain with hypesthesia and/or dysesthesia in the distribution of the ophthalmic division of the trigeminal nerve, along with ptosis and miosis. (See
         <a class="local">
          'Paratrigeminal oculosympathetic syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Recurrent painful ophthalmoplegic neuropathy
         </strong>
         is characterized by repeated attacks of paralysis of one or more ocular cranial nerves, typically cranial nerve III, with ipsilateral headache. (See
         <a class="local">
          'Recurrent painful ophthalmoplegic neuropathy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Burning mouth syndrome
         </strong>
         is characterized by an intraoral burning sensation for which no medical or dental cause can be found. The pain may be restricted to the tongue or just the tip of the tongue and may be associated with dysesthesia, altered taste, and/or a sensation of having a dry mouth. (See
         <a class="local">
          'Burning mouth syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Red ear syndrome
         </strong>
         is an uncommon entity characterized by unilateral erythema and burning pain of the ear and adjacent face or hemicranium. Symptoms may occur spontaneously or be triggered by touch, heat, neck movement, eating, or other stimuli. (See
         <a class="local">
          'Red ear syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Persistent idiopathic facial pain
         </strong>
         is characterized by persistent facial and/or oral pain in the absence of a neurologic deficit. Minor surgery or injury to the face, teeth, or gums may initiate the symptoms, which persist after healing without a clear local cause. The pain is commonly felt in the nasolabial fold or one side of the chin but can spread to wider areas of the face and neck. (See
         <a class="local">
          'Persistent idiopathic facial pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Central neuropathic pain
         </strong>
         is caused by a lesion or dysfunction in the central nervous system. The two main recognized causes are central neuropathic pain attributed to multiple sclerosis and central poststroke pain. (See
         <a class="local">
          'Central neuropathic facial pain'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/3324.html" rel="external">
          "Central neuropathic facial pain"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other causes of craniofacial pain
         </strong>
         include cancer, dental pain, temporomandibular joint syndrome, giant cell arteritis, noninflammatory lesions affecting the cervical carotid or vertebral arteries, post-traumatic and postoperative pain, and primary headaches. (See
         <a class="local">
          'Secondary causes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4142672354">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Zahid H Bajwa, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rowbotham MC. Mechanisms of neuropathic pain and their implications for the design of clinical trials. Neurology 2005; 65:S66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith JH, Cutrer FM. Numbness matters: a clinical review of trigeminal neuropathy. Cephalalgia 2011; 31:1131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blomstedt PC, Bergenheim AT. Technical difficulties and perioperative complications of retrogasserian glycerol rhizotomy for trigeminal neuralgia. Stereotact Funct Neurosurg 2002; 79:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ischia S, Luzzani A, Polati E. Retrogasserian glycerol injection: a retrospective study of 112 patients. Clin J Pain 1990; 6:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujimaki T, Fukushima T, Miyazaki S. Percutaneous retrogasserian glycerol injection in the management of trigeminal neuralgia: long-term follow-up results. J Neurosurg 1990; 73:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sahni KS, Pieper DR, Anderson R, Baldwin NG. Relation of hypesthesia to the outcome of glycerol rhizolysis for trigeminal neuralgia. J Neurosurg 1990; 72:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young RF. Glycerol rhizolysis for treatment of trigeminal neuralgia. J Neurosurg 1988; 69:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mathews ES, Scrivani SJ. Percutaneous stereotactic radiofrequency thermal rhizotomy for the treatment of trigeminal neuralgia. Mt Sinai J Med 2000; 67:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanpolat Y, Savas A, Bekar A, Berk C. Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients. Neurosurgery 2001; 48:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ischia S, Luzzani A, Polati E, Ischia A. Percutaneous controlled thermocoagulation in the treatment of trigeminal neuralgia. Clin J Pain 1990; 6:96.
          </a>
         </li>
         <li class="breakAll">
          Heros RC, Heros DA, Schumacher JM, Marsden CD. Principles of neurosurgery. In: Neurology in Clinical Practice, Bradley WG, Daroff RB, Fenichel GM (Eds), Butterworth Heinemann, Philadelphia 2004. p.963.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elloumi-Jellouli A, Ben Ammar S, Fenniche S, et al. Trigeminal trophic syndrome: a report of two cases with review of literature. Dermatol Online J 2003; 9:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadeghi P, Papay FA, Vidimos AT. Trigeminal trophic syndrome--report of four cases and review of the literature. Dermatol Surg 2004; 30:807.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garza I. The trigeminal trophic syndrome: an unusual cause of face pain, dysaesthesias, anaesthesia and skin/soft tissue lesions. Cephalalgia 2008; 28:980.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sawada T, Asai J, Nomiyama T, et al. Trigeminal trophic syndrome: report of a case and review of the published work. J Dermatol 2014; 41:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Golden E, Robertson CE, Moossy JJ, et al. Trigeminal trophic syndrome: A rare cause of chronic facial pain and skin ulcers. Cephalalgia 2015; 35:636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collyer S, Fuller G. Trigeminal trophic syndrome. Pract Neurol 2012; 12:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Willis M, Shockley WW, Mobley SR. Treatment options in trigeminal trophic syndrome: a multi-institutional case series. Laryngoscope 2011; 121:712.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watson P, Evans R. Cluster-tic syndrome. Headache 1985; 25:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alberca R, Ochoa JJ. Cluster tic syndrome. Neurology 1994; 44:996.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulleners WM, Verhagen WI. Cluster-tic syndrome. Neurology 1996; 47:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilbrink LA, Weller CM, Cheung C, et al. Cluster-tic syndrome: a cross-sectional study of cluster headache patients. Headache 2013; 53:1334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambru G, Matharu MS. SUNCT, SUNA and trigeminal neuralgia: different disorders or variants of the same disorder? Curr Opin Neurol 2014; 27:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           VanderPluym J, Richer L. Tic versus TAC: differentiating the neuralgias (trigeminal neuralgia) from the cephalalgias (SUNCT and SUNA). Curr Pain Headache Rep 2015; 19:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pascual J, Berciano J. Relief of cluster-tic syndrome by the combination of lithium and carbamazepine. Cephalalgia 1993; 13:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Payán Ortiz M, Guardado Santervás P, Arjona Padillo A, Aguilera del Moral A. Cluster-tic syndrome as the first clinical manifestation of a dural carotid-cavernous fistula. Neurologia 2014; 29:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Coo I, van Dijk JM, Metzemaekers JD, Haan J. A Case Report About Cluster-Tic Syndrome Due to Venous Compression of the Trigeminal Nerve. Headache 2017; 57:654.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           González-Quintanilla V, Oterino A, Toriello M, et al. Cluster-tic syndrome as the initial manifestation of multiple sclerosis. J Headache Pain 2012; 13:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Solomon S, Apfelbaum RI, Guglielmo KM. The cluster-tic syndrome and its surgical therapy. Cephalalgia 1985; 5:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duvall JR, Garza I, Kissoon NR, Robertson CE. Great Auricular Neuralgia: Case Series. Headache 2020; 60:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blumenthal HJ. Great auricular neuralgia. Headache 1992; 32:413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Neill F, Nurmikko T, Sommer C. Other facial neuralgias. Cephalalgia 2017; 37:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Speciali JG, Gonçalves DA. Auriculotemporal neuralgia. Curr Pain Headache Rep 2005; 9:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ansari H, Robertson CE, Lane JI, et al. Auriculotemporal neuralgia secondary to TMJ synovial cyst: a rare presentation of a rare entity. Headache 2013; 53:1662.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mokri B. Raeder's paratrigeminal syndrome. Original concept and subsequent deviations. Arch Neurol 1982; 39:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goadsby PJ. Raeder's syndrome [corrected]: paratrigeminal paralysis of the oculopupillary sympathetic system. J Neurol Neurosurg Psychiatry 2002; 72:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu Y, Wang M, Bian X, et al. Proposed modified diagnostic criteria for recurrent painful ophthalmoplegic neuropathy: Five case reports and literature review. Cephalalgia 2020; 40:1657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi JY, Jang SH, Park MH, et al. Ophthalmoplegic migraine with alternating unilateral and bilateral internal ophthalmoplegia. Headache 2007; 47:726.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ. Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol 2012; 27:759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lance JW, Zagami AS. Ophthalmoplegic migraine: a recurrent demyelinating neuropathy? Cephalalgia 2001; 21:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friedman DI. The ophthalmoplegic migraines: a proposed classification. Cephalalgia 2010; 30:646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lane R, Davies P. Ophthalmoplegic migraine: the case for reclassification. Cephalalgia 2010; 30:655.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen PK, Wang SJ. Ophthalmoplegic migraine: migraine variant or cranial neuralgia? Cephalalgia 2012; 32:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margari L, Legrottaglie AR, Craig F, et al. Ophthalmoplegic migraine: migraine or oculomotor neuropathy? Cephalalgia 2012; 32:1208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ambrosetto P, Nicolini F, Zoli M, et al. Ophthalmoplegic migraine: from questions to answers. Cephalalgia 2014; 34:914.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawasaki A. Oculomotor nerve schwannoma associated with ophthalmoplegic migraine. Am J Ophthalmol 1999; 128:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murakami T, Funatsuka M, Komine M, et al. Oculomotor nerve schwannoma mimicking ophthalmoplegic migraine. Neuropediatrics 2005; 36:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bisdorff AR, Wildanger G. Oculomotor nerve schwannoma mimicking ophthalmoplegic migraine. Cephalalgia 2006; 26:1157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akimoto J, Fukami S, Hashimoto R, Haraoka J. Neuromuscular hamartoma is a possible primary pathology of oculomotor ophthalmoplegic migraine. Cephalalgia 2012; 32:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim R, Kim JH, Kim E, et al. Oculomotor nerve tumors masquerading as recurrent painful ophthalmoplegic neuropathy: report of two cases and review of the literature. Cephalalgia 2015; 35:825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kohorst JJ, Bruce AJ, Torgerson RR, et al. A population-based study of the incidence of burning mouth syndrome. Mayo Clin Proc 2014; 89:1545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Su NY, Wang YH, Chang YC. A nationwide register-based study of the prevalence of burning mouth syndrome in Taiwan from 2004 to 2013. J Dent Sci 2021; 16:1074.
          </a>
         </li>
         <li class="breakAll">
          Cranial neuralgias and central causes of facial pain. In: Mechanism and management of headache, Lance JW, Goadsby PJ (Eds), Elsevier Butterworth Heinemann, Philadelphia 2005. p.333.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wessman LL, Andersen LK, Davis MDP. Incidence of diseases primarily affecting the skin by age group: population-based epidemiologic study in Olmsted County, Minnesota, and comparison with age-specific incidence rates worldwide. Int J Dermatol 2018; 57:1021.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JY, Kim YS, Ko I, Kim DK. Association Between Burning Mouth Syndrome and the Development of Depression, Anxiety, Dementia, and Parkinson Disease. JAMA Otolaryngol Head Neck Surg 2020; 146:561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galli F, Lodi G, Sardella A, Vegni E. Role of psychological factors in burning mouth syndrome: A systematic review and meta-analysis. Cephalalgia 2017; 37:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feller L, Fourie J, Bouckaert M, et al. Burning Mouth Syndrome: Aetiopathogenesis and Principles of Management. Pain Res Manag 2017; 2017:1926269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother 2008; 8:781.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stuginski-Barbosa J, Rodrigues GG, Bigal ME, Speciali JG. Burning mouth syndrome responsive to pramipexol. J Headache Pain 2008; 9:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cárcamo Fonfría A, Gómez-Vicente L, Pedraza MI, et al. Burning mouth syndrome: Clinical description, pathophysiological approach, and a new therapeutic option. Neurologia 2017; 32:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans RW, Drage LA. Burning mouth syndrome. Headache 2005; 45:1079.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maltsman-Tseikhin A, Moricca P, Niv D. Burning mouth syndrome: will better understanding yield better management? Pain Pract 2007; 7:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lechien JR, Hans S, De Marrez LG, et al. Prevalence and Features of Laryngopharyngeal Reflux in Patients with Primary Burning Mouth Syndrome. Laryngoscope 2021; 131:E2627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan HL, Smith JG, Hoffmann J, Renton T. A systematic review of treatment for patients with burning mouth syndrome. Cephalalgia 2022; 42:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cabras M, Gambino A, Broccoletti R, et al. Effectiveness of Nonpharmacologic Treatments of Burning Mouth Syndrome: A Systematic Review. J Oral Facial Pain Headache 2021; 35:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raieli V, Compagno A, D'Amelio M. Red Ear Syndrome. Curr Pain Headache Rep 2016; 20:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar N, Swanson JW. The 'red ear syndrome' revisited: two cases and a review of literature. Cephalalgia 2004; 24:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramirez CC, Kirsner RS. A refractory case of erythromelalgia involving the ears. Am J Otolaryngol 2004; 25:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brill TJ, Funk B, Thaçi D, Kaufmann R. Red ear syndrome and auricular erythromelalgia: the same condition? Clin Exp Dermatol 2009; 34:e626.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lance JW. The red ear syndrome. Neurology 1996; 47:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sklebar D, Sklebar I, Vrabec-Matković D, Cengić L. Red ear syndrome--chronic pain syndrome of low prevalence. Acta Clin Croat 2010; 49:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Selekler M, Kutlu A, Uçar S, Almaç A. Immediate response to greater auricular nerve blockade in red ear syndrome. Cephalalgia 2009; 29:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eismann R, Gaul C, Wohlrab J, et al. Red ear syndrome: case report and review of the literature. Dermatology 2011; 223:196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raieli V, Monastero R, Santangelo G, et al. Red ear syndrome and migraine: report of eight cases. Headache 2002; 42:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dieleman JP, Kerklaan J, Huygen FJ, et al. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 2008; 137:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manzoni GC, Torelli P. Epidemiology of typical and atypical craniofacial neuralgias. Neurol Sci 2005; 26 Suppl 2:s65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziegeler C, Brauns G, May A. Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain. Headache 2021; 61:1441.
          </a>
         </li>
         <li class="breakAll">
          Boes CJ, Copobianco DJ, Cutrer FM, et al. Headache and other craniofacial pain. In: Neurology in clinical practice, Bradley WG, Daroff RB, Fenichel GM, et al (Eds), Butterworth Heinemann, Philadelphia 2004. p.2055.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galhardoni R, Ciampi de Andrade D, Puerta MY, et al. Altered cortical excitability in persistent idiopathic facial pain. Cephalalgia 2019; 39:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agostoni E, Frigerio R, Santoro P. Atypical facial pain: clinical considerations and differential diagnosis. Neurol Sci 2005; 26 Suppl 2:s71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Volcy M, Rapoport AM, Tepper SJ, et al. Persistent idiopathic facial pain responsive to topiramate. Cephalalgia 2006; 26:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graff-Radford SB. Facial pain. Neurologist 2009; 15:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanbro M, Gray BH, Kellicut DC. Carotidynia: revisiting an unfamiliar entity. Ann Vasc Surg 2011; 25:1144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jaeger B, Singer E, Kroening R. Reflex sympathetic dystrophy of the face. Report of two cases and a review of the literature. Arch Neurol 1986; 43:693.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3355 Version 36.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29368949" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16385106" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Mechanisms of neuropathic pain and their implications for the design of clinical trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21628435" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Numbness matters: a clinical review of trigeminal neuropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12890975" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Technical difficulties and perioperative complications of retrogasserian glycerol rhizotomy for trigeminal neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2135029" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Retrogasserian glycerol injection: a retrospective study of 112 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2195139" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Percutaneous retrogasserian glycerol injection in the management of trigeminal neuralgia: long-term follow-up results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2294185" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Relation of hypesthesia to the outcome of glycerol rhizolysis for trigeminal neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2454304" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Glycerol rhizolysis for treatment of trigeminal neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11021779" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Percutaneous stereotactic radiofrequency thermal rhizotomy for the treatment of trigeminal neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11270542" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2135010" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Percutaneous controlled thermocoagulation in the treatment of trigeminal neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2135010" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Percutaneous controlled thermocoagulation in the treatment of trigeminal neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14996399" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Trigeminal trophic syndrome: a report of two cases with review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15099331" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Trigeminal trophic syndrome--report of four cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18557978" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The trigeminal trophic syndrome: an unusual cause of face pain, dysaesthesias, anaesthesia and skin/soft tissue lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24807466" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Trigeminal trophic syndrome: report of a case and review of the published work.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25147332" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Trigeminal trophic syndrome: A rare cause of chronic facial pain and skin ulcers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22976067" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Trigeminal trophic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21433016" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Treatment options in trigeminal trophic syndrome: a multi-institutional case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4008248" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Cluster-tic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8208435" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Cluster tic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8710105" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Cluster-tic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23808839" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Cluster-tic syndrome: a cross-sectional study of cluster headache patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24792341" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : SUNCT, SUNA and trigeminal neuralgia: different disorders or variants of the same disorder?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25501956" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Tic versus TAC: differentiating the neuralgias (trigeminal neuralgia) from the cephalalgias (SUNCT and SUNA).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8358779" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Relief of cluster-tic syndrome by the combination of lithium and carbamazepine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22938945" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Cluster-tic syndrome as the first clinical manifestation of a dural carotid-cavernous fistula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27925184" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : A Case Report About Cluster-Tic Syndrome Due to Venous Compression of the Trigeminal Nerve.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22543446" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Cluster-tic syndrome as the initial manifestation of multiple sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4016920" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : The cluster-tic syndrome and its surgical therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31749202" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Great Auricular Neuralgia: Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1399564" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Great auricular neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28133989" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Other facial neuralgias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16004845" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Auriculotemporal neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24020967" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Auriculotemporal neuralgia secondary to TMJ synovial cyst: a rare presentation of a rare entity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7103769" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Raeder's paratrigeminal syndrome. Original concept and subsequent deviations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11861683" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Raeder's syndrome [corrected]: paratrigeminal paralysis of the oculopupillary sympathetic system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32722935" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Proposed modified diagnostic criteria for recurrent painful ophthalmoplegic neuropathy: Five case reports and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17501857" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Ophthalmoplegic migraine with alternating unilateral and bilateral internal ophthalmoplegia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22241707" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11422088" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Ophthalmoplegic migraine: a recurrent demyelinating neuropathy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19732067" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : The ophthalmoplegic migraines: a proposed classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19673904" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Ophthalmoplegic migraine: the case for reclassification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22345631" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Ophthalmoplegic migraine: migraine variant or cranial neuralgia?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23150890" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Ophthalmoplegic migraine: migraine or oculomotor neuropathy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24567117" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Ophthalmoplegic migraine: from questions to answers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10577548" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Oculomotor nerve schwannoma associated with ophthalmoplegic migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16429381" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Oculomotor nerve schwannoma mimicking ophthalmoplegic migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16919070" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Oculomotor nerve schwannoma mimicking ophthalmoplegic migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22174363" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Neuromuscular hamartoma is a possible primary pathology of oculomotor ophthalmoplegic migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25366549" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Oculomotor nerve tumors masquerading as recurrent painful ophthalmoplegic neuropathy: report of two cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25176397" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : A population-based study of the incidence of burning mouth syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34484572" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : A nationwide register-based study of the prevalence of burning mouth syndrome in Taiwan from 2004 to 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34484572" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : A nationwide register-based study of the prevalence of burning mouth syndrome in Taiwan from 2004 to 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29377079" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Incidence of diseases primarily affecting the skin by age group: population-based epidemiologic study in Olmsted County, Minnesota, and comparison with age-specific incidence rates worldwide.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32352482" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Association Between Burning Mouth Syndrome and the Development of Depression, Anxiety, Dementia, and Parkinson Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27121358" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Role of psychological factors in burning mouth syndrome: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29180911" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Burning Mouth Syndrome: Aetiopathogenesis and Principles of Management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15911160" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18457535" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Role of central dopamine in pain and analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18219443" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Burning mouth syndrome responsive to pramipexol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26778734" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Burning mouth syndrome: Clinical description, pathophysiological approach, and a new therapeutic option.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16109125" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Burning mouth syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17559486" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Burning mouth syndrome: will better understanding yield better management?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34009647" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Prevalence and Features of Laryngopharyngeal Reflux in Patients with Primary Burning Mouth Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34404247" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : A systematic review of treatment for patients with burning mouth syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34609377" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Effectiveness of Nonpharmacologic Treatments of Burning Mouth Syndrome: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26879877" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Red Ear Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15030541" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : The 'red ear syndrome' revisited: two cases and a review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15239031" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : A refractory case of erythromelalgia involving the ears.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19489849" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Red ear syndrome and auricular erythromelalgia: the same condition?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8797453" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : The red ear syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21462824" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Red ear syndrome--chronic pain syndrome of low prevalence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19291247" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Immediate response to greater auricular nerve blockade in red ear syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21985901" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Red ear syndrome: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12005292" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Red ear syndrome and migraine: report of eight cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18439759" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Incidence rates and treatment of neuropathic pain conditions in the general population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15926023" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Epidemiology of typical and atypical craniofacial neuralgias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34618363" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34618363" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29898612" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Altered cortical excitability in persistent idiopathic facial pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15926025" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Atypical facial pain: clinical considerations and differential diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16556253" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Persistent idiopathic facial pain responsive to topiramate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19590376" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Facial pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22023945" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Carotidynia: revisiting an unfamiliar entity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3729748" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Reflex sympathetic dystrophy of the face. Report of two cases and a review of the literature.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
